Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.62 +0.02 (+0.77%)
At close: Aug 20, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) EBITDA Margin (QoQ) (2016 - 2024)

Kiora Pharmaceuticals (KPRX) EBITDA Margin (QoQ) (2016 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Kiora Pharmaceuticals 16.25 Mn 16.25 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.28 Mn
Sep 30, 2018 14,582.00
Jun 30, 2018 -93,921.00
Sep 30, 2017 -329,917.00
Jun 30, 2017 -66,127.00
Sep 30, 2016 39,973.00